SANTA ROSA, Calif., Jan. 28, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today announced that its management will be participating in two upcoming investor conferences.
TriVascular management is scheduled to present at the 2015 Leerink Global Healthcare Conference in New York City on Thursday, February 12, 2015 at 3:05pm ET. Interested individuals can access the live audio webcast on the investor relations section of the Company's website at: http://www.trivascular.com. The webcast will be available on the Company's website for two weeks following completion of the presentation.
TriVascular management will also participate in BTIG's Second Annual Snowbird Medical Technology, Diagnostics, and Healthcare IT Conference on Thursday, February 19, 2015. The conference takes place in Snowbird, UT from February 18-20, 2015. The conference format consists of one-on-one meetings and will not be webcast.
About TriVascular Technologies, Inc. - TriVascular is a medical device company developing and commercializing innovative technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company manufactures the Ovation Prime Abdominal Stent Graft System, the lowest profile FDA-approved endovascular aortic repair (EVAR) system, which utilizes a novel, polymer-based sealing mechanism. TriVascular is based in Santa Rosa, California.